Effect of obesity on the association between ATF3 gene haplotypes and C-reactive protein level in Taiwanese

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 1026-1031

  Wu, Semon ^a,b   Hsu, Lung An ^c   Cheng, Ching Feng ^b,d   Teng, Ming Sheng ^b   Chou, Hsin Hua ^b   Lin, Heng ^b   Chang, Pi Yueh ^e   Ko, Yu Lin ^b,d  

^a CHINESE CULTURE UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ATF3 gene; C reactive protein; Gene association study; Haplotype; Interaction; Polymorphism

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE MARKER; EVIDENCE BASED MEDICINE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

ACTIVATING TRANSCRIPTION FACTOR 3; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 79955011355     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.02.011     Document Type: Article

References (35)

1. Hai T., Hartman M.G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273:1-11.
2. Hai T., Wolfgang C.D., Marsee D.K., Allen A.E., Sivaprasad U. ATF3 and stress responses. Gene Expr 1999, 7:321-335.
3. Chen B.P., Wolfgang C.D., Hai T. Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell Biol 1996, 16:1157-1168.
4. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
5. Gilchrist M., Thorsson V., Li B., et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
6. Whitmore M.M., Iparraguirre A., Kubelka L., et al. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol 2007, 179:3622-3630.
7. Willingham E., Baskin L.S. Candidate genes and their response to environmental agents in the etiology of hypospadias. Nat Clin Pract Urol 2007, 4:270-279.
8. Kalfa N., Liu B., Klein O., et al. Genomic variants of ATF3 in patients with hypospadias. J Urol 2008, 180:2183-2188.
9. Reiner A.P., Barber M.J., Guan Y., et al. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008, 82:1193-1201.
10. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
11. Tan C.E., Ma S., Wai D., Chew S.K., Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diab Care 2004, 27:1182-1186.
12. Ko Y.L., Hsu L.A., Hsu K.H., Ko Y.H., Lee Y.S. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Atherosclerosis 2004, 172:135-142.
13. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37:1217-1223.
14. Sole X., Guino E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
15. Ridker P.M., Pare G., Parker A., et al. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008, 82:1185-1192.
16. Elliott P., Chambers J.C., Zhang W., et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009, 302:37-48.
17. Teng M.S., Hsu L.A., Wu S., Chang H.H., Ko Y.L. Association between C-reactive protein gene haplotypes and C-reactive protein levels in Taiwanese: Interaction with obesity. Atherosclerosis 2009, 204:e64-e69.
18. Kaszubska W., Hooft van Huijsduijnen R., Ghersa P., et al. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol 1993, 13:7180-7190.
19. Nawa T., Nawa M.T., Adachi M.T., et al. Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 2002, 16:281-291.
20. Khuu C.H., Barrozo R.M., Hai T., Weinstein S.L. Activating transcription factor 3 (ATF3) represses the expression of CCL4 in murine macrophages. Mol Immunol 2007, 44:1598-1605.
21. Yan C., Wang H., Boyd D.D. ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem 2002, 277:10804-10812.
22. Chen S.C., Liu Y.C., Shyu K.G., Wang D.L. Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 2008, 201:281-288.
23. Ho H.H., Antoniv T.T., Ji J.D., Ivashkiv L.B. Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1. J Immunol 2008, 181:5089-5097.
24. Zmuda E.J., Qi L., Zhu M.X., et al. The roles of ATF3, an adaptive-response gene, in high-fat-diet-induced diabetes and pancreatic beta-cell dysfunction. Mol Endocrinol 2010, 24:1423-1433.
25. Li H.F., Cheng C.F., Liao W.J., Lin H., Yang R.B. ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol 2010, 21:1003-1013.
26. Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20:2438-2452.
27. Suganami T., Yuan X., Shimoda Y., et al. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 2009, 105:25-32.
28. Kim H.B., Kong M., Kim T.M., et al. NFATc4 and ATF3 negatively regulate adiponectin gene expression in 3T3-L1 adipocytes. Diabetes 2006, 55:1342-1352.
29. Devaraj S., Torok N., Dasu M.R., Samols D., Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 2008, 28:1368-1374.
30. Kawauchi J., Zhang C., Nobori K., et al. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 2002, 277:39025-39034.
31. Zhang L., Liu Y., Lu X.T., et al. Intraplaque injection of Ad5-CMV.p53 aggravates local inflammation and leads to plaque instability in rabbits. J Cell Mol Med 2009, 13:2713-2723.
32. Panoulas V.F., Stavropoulos-Kalinoglou A., Metsios G.S., et al. Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis 2009, 204:178-183.
33. Melander O., Newton-Cheh C., Almgren P., et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009, 302:49-57.
34. Blake G.J., Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 2001, 89:763-771.
35. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.